Stockscreener 앱 받기
29.68
5.70%
1.60
시장 영업 전:
29.73
0.05
+0.17%
Galecto Inc 주식(GLTO)의 최신 뉴스
Galecto Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Bitget
Galecto (GLTO) Issues Equity Awards to New Employees - GuruFocus
Galecto announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Biotech Galecto gives new hires options for 153,700 shares - Stock Titan
Galecto, Inc. (NASDAQ:GLTO) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Market Trends: Can Galecto Inc generate free cash flowEarnings Beat & Capital Protection Trading Alerts - baoquankhu1.vn
Galecto to Participate in Leerink Partners 2026 Global Healthcare Conference - Bitget
Galecto, Inc. (NASDAQ:GLTO) Short Interest Up 86.6% in February - Defense World
Market Moves: What are Galecto Incs growth leversWeekly Risk Report & Breakout Confirmation Trade Signals - baoquankhu1.vn
Update Report: Can Galecto Inc beat the S P 500Chart Signals & Growth Focused Stock Pick Reports - baoquankhu1.vn
Bull Bear: How sensitive is Galecto Inc to inflationShort Setup & AI Enhanced Trading Alerts - baoquankhu1.vn
GLTO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Stock Market Recap: Whats the profit margin of Galecto IncEarnings Growth Report & Real-Time Volume Spike Alerts - baoquankhu1.vn
Will Galecto Inc. stock hit new highs in YEARPortfolio Return Report & Free Real-Time Market Sentiment Alerts - mfd.ru
Analysts Offer Insights on Healthcare Companies: Establishment Labs Holdings (ESTA) and Galecto (GLTO) - The Globe and Mail
UBS initiates Galecto stock with buy rating on blood disorder drug - Investing.com Nigeria
GLTO: UBS Initiates Coverage with a 'Buy' Rating and $45 PT | GL - GuruFocus
UBS Initiates Coverage of Galecto (GLTO) with Buy Recommendation - Nasdaq
GLTO: Guggenheim Maintains Buy Rating and Raises Price Target to $40 | GLTO Stock News - GuruFocus
Galecto (GLTO) Is Up 21.3% After $316 Million Equity Raise and New $150 Million Shelf Registration - simplywall.st
Galecto (GLTO) Is Up 15.3% After $316 Million Equity Raise And New Shelf RegistrationWhat's Changed - Yahoo Finance
Galecto Closes $316 Million Public Offering of Common Stock - Global Legal Chronicle
Assessing Galecto (GLTO) Valuation After Sharp Short-Term Share Price Momentum - Yahoo Finance
Can Galecto Inc. lead its sector in growthJuly 2025 Gainers & Expert Verified Movement Alerts - mfd.ru
What is Galecto Inc.’s valuation compared to sector2025 Winners & Losers & Weekly Stock Performance Updates - mfd.ru
Galecto Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $316.3 Million - The Manila Times
Why Galecto Inc. stock could be next big winnerDip Buying & AI Enhanced Market Trend Forecasts - mfd.ru
Galecto Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares for Gross Proceeds of $316.3 Million - Bitget
Galecto raises $316.3M as it develops blood cancer therapies - Stock Titan
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Dividend Watch: Can Galecto Inc lead its sector in growthEarnings Miss & High Conviction Buy Zone Picks - baoquankhu1.vn
Galecto prices $275 million public offering at $19 per share By Investing.com - Investing.com Nigeria
Galecto Prices Upsized Public Offering to Fund DMR-001 - TipRanks
Galecto Signs Underwriting Agreement With Jefferies and Leerink Partners - TradingView
Galecto Prices Public Offering at $19.00 per Share, Expected to Raise $275M - Intellectia AI
Galecto shares fall after $275 million equity raise at discount - Investing.com
Galecto shares fall after $275 million equity raise at discount By Investing.com - Investing.com Canada
GLTO: Key Managers Involved in Recent Offering - GuruFocus
Galecto to raise USD 275m in share issue - medwatch.com
Galecto announces public offering of common stock and preferred shares By Investing.com - Investing.com Australia
Galecto Prices $275 Mln Public Offering At $19 Per Share, Stock Down - Nasdaq
Cancer drug developer Galecto raises $275M in stock sale - Stock Titan
Hans Schambye resigns from Galecto – takes top position at Boost Pharma - medwatch.com
Galecto Announces Proposed Underwritten Public Offering of Common Stock and Preferred Stock - 富途牛牛
Galecto Prices $275 Million Offering - marketscreener.com
Galecto stock falls after announcing public offering of common stock By Investing.com - Investing.com Canada
Galecto prices $275 million public offering at $19 per share - Investing.com India
Galecto Announces Pricing of $275 Million Underwritten Public Offering - The Manila Times
Galecto, Inc. Announces Pricing of $275 Million Underwritten Public Offering of Common Stock - Quiver Quantitative
Galecto announces pricing of $275 million underwritten public offering - marketscreener.com
0.11%
6.00%
자본화:
|
볼륨(24시간):